Morning versus bedtime insulin glargine in combination with glimepiride: No difference in incidence of nocturnal hypoglycemia in patients with type 2 diabetes

被引：0
|
作者：
Standl, E
Maxeiner, S
Schweitzer, MA
机构：
来源：
DIABETES | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A134 / A134
页数：1
相关论文
共 50 条
  • [41] Efficacy and Safety of Once-Weekly Dulaglutide Versus Insulin Glargine in Patients With Type 2 Diabetes on Metformin and Glimepiride (AWARD-2)
    Giorgino, Francesco
    Benroubi, Marian
    Sun, Jui-Hung
    Zimmermann, Alan G.
    Pechtner, Valeria
    [J]. DIABETES CARE, 2015, 38 (12) : 2241 - 2249
  • [42] Angiotensin profiles in patients with type 2 diabetes and combination therapy of empagliflozin and linagliptin versus metformin and insulin glargine
    Bosch, A.
    Poglitsch, M.
    Kannenkeril, D.
    Ott, C.
    Striepe, K.
    Schmieder, R. E.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 256 - 256
  • [43] Physical Health Status and Nocturnal Hypoglycemia With Insulin Degludec vs. Insulin Glargine: A 2-Year Trial in Insulin-Naive Patients With Type 2 Diabetes
    Rodbard, Helena W.
    Cariou, Bertrand
    Zinman, Bernard
    Han-Delsman, Yehuda
    Wolden, Michael L.
    Rana, Azhar
    Mathieu, Chantal
    [J]. DIABETES, 2013, 62 : A237 - A238
  • [44] Less symptomatic hypoglycemia with insulin glargine compared to NPH in patients with type 2 diabetes.
    Fonseca, V
    Bell, D
    Mecca, T
    [J]. DIABETOLOGIA, 2001, 44 : A207 - A207
  • [45] Insulin detemir versus insulin glargine for type 2 diabetes mellitus
    Swinnen, Sanne G.
    Simon, Airin C. R.
    Holleman, Frits
    Hoekstra, Joost B.
    DeVries, J. Hans
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (07):
  • [46] Insulin detemir versus insulin glargine for type 2 diabetes mellitus
    Simon, A. C. R.
    Swinnen, S. G.
    Holleman, F.
    Hoekstra, J. B. L.
    DeVries, J. H.
    [J]. DIABETOLOGIA, 2011, 54 : S420 - S421
  • [47] Repaglinide versus sulfonylurea in combination with bedtime NPH insulin in patients with type 2 diabetes with secondary failure to oral treatment
    Strojek, K
    Polaszewska-Muszynska, M
    Krassowski, J
    Gumprecht, J
    Rudzki, H
    Olejniczak, H
    Nazar, M
    [J]. DIABETES, 2003, 52 : A135 - A135
  • [48] Efficacy of insulin glargine and glimepiride in controlling blood glucose of ethnic Japanese patients with type 2 diabetes mellitus
    Kawamori, Ryuzo
    Eliaschewitz, Freddy G.
    Takayama, Hideichi
    Hayashida, Cesar Y.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 (01) : 97 - 102
  • [49] ANGIOTENSIN PROFILES IN PATIENTS WITH HYPERTENSION AND TYPE 2 DIABETES WITH COMBINATION THERAPY OF EMPAGLIFLOZIN AND LINAGLIPTIN VERSUS METFORMIN AND INSULIN GLARGINE
    Bosch, Agnes
    Poglitsch, Marko
    Kannenkeril, Dennis
    Ott, Christian
    Pietschner, Robert
    Striepe, Kristina
    Schiffer, Mario
    Schmieder, Roland E.
    [J]. JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL 1) : E283 - E284
  • [50] Decreased Fear of Hypoglycemia Following Initiation of Insulin Glargine in Suboptimally Controlled Type 2 Diabetes Patients
    Hajos, Tibor
    Pouwer, Frans
    De Grooth, Ricardo
    Twisk, Jos W. R.
    Holleman, Frits
    Diamant, Michaela
    Snoek, Frank J.
    [J]. DIABETES, 2010, 59 : A518 - A518
12345